Neurological disorders, including epilepsy, Alzheimer’s, Parkinson’s, multiple sclerosis, migraine and stroke are leading causes of disability and death in the Middle East. Increasing life expectancy means that more people are now reaching ages where neurological disorders are most prevalent. The number of patients receiving neuropsychiatric care for conditions such as depression will also continue to grow in coming decades. Pharmax has started to produce a broad range of pharmaceuticals for treating CNS diseases, with impeccable quality coupled with affordable treatment costs as our core focus.

Escitomax

Molecule : Escitalopram

Available Strength : 10mg, 20mg

Venlift XR

Molecule : Venlafaxine

Available Strength : 75mg, 150mg

Jubitran ODT

Molecule : Zolmitriptan

Available Strength : 2.5mg, 5mg

Copyright 2020 – Pharmax Pharmaceuticals FZ-LLC. All Rights Reserved.

Ministry of Health Health and Prevention Advertisement License No : IN0W3681-140720 valid till 15/07/2021